Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii

被引:62
作者
Chen, Te-Li [1 ,2 ]
Wu, Roy Chen-Chih [2 ]
Shaio, Men-Fang [3 ]
Fung, Chang-Phone [1 ,2 ]
Cho, Wen-Long [2 ]
机构
[1] Natl Yang Ming Univ, Sch Med, Div Infect Dis, Taipei 112, Taiwan
[2] Taipei Vet Gen Hosp, Dept Internal Med, Inst Trop Med, Taipei, Taiwan
[3] Hung Kuang Univ, Div Clin Res, Dept Med Res, Kuang Tien Gen Hosp,Inst Clin Nutr, Taichung, Taiwan
关键词
D O I
10.1128/AAC.00393-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The oxacillinase gene was reported to confer limited resistance to carbapenem in Acinetobacter baumannii. In this study, we have demonstrated that an A. baumannii clinical isolate harboring a plasmid, pTVICU53, has 11,037 bp encoding 13 open reading frames. A bla(OXA-58) gene with an upstream insertion of truncated ISAba3 (Delta ISAba3) and IS1008 was found in this plasmid. Delta ISAba3 and IS1008 provided two independent promoters for the transcription control of the bla(OXA-58) gene. The transformation of pTVICU53 or a shuttle vector bearing IS1008-Delta ISAba3-bla(OXA-58) to different A. baumannii recipients can increase their MICs of carbapenem 64- to 256-fold. The deletion of promoters provided by IS1008 resulted in dramatic decreases in bla(OXA-58) transcription and a 32- to 64-fold reduction in the carbapenem MIC. These findings highlight that A. baumannii might develop carbapenem resistance with a single transformation step, taking up a plasmid containing a genetic construct with a potentially high level of transcription of the bla(OXA-58) gene.
引用
收藏
页码:2573 / 2580
页数:8
相关论文
共 37 条
  • [1] [Anonymous], 2001, Anal Biochem
  • [2] Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features
    BergogneBerezin, E
    Towner, KJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) : 148 - +
  • [3] Multicopy blaOXA-58 gene as a source of high-Level resistance to carbapenems in Acinetobacter baumannii
    Bertini, Alessia
    Poirel, Laurent
    Bernabeu, Sandrine
    Fortini, Daniela
    Villa, Laura
    Nordmann, Patrice
    Carattoli, Alessandra
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) : 2324 - 2328
  • [4] The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT
    Bettegowda, Chetan
    Huang, Xin
    Lin, Jimmy
    Cheong, Ian
    Kohli, Manu
    Szabo, Stephen A.
    Zhang, Xiaosong
    Diaz, Luis A., Jr.
    Velculescu, Victor E.
    Parmigiani, Giovanni
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Zhou, Shibin
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (12) : 1573 - 1580
  • [5] Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases
    Bou, G
    Cerveró, G
    Domínguez, MA
    Quereda, C
    Martínez-Beltrán, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) : 3299 - 3305
  • [6] OXA β-lactamases in Acinetobacter:: the story so far
    Brown, S
    Amyes, S
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (01) : 1 - 3
  • [7] Evolution of multidrug-resistant Acinetobacter baumannii isolates obtained from elderly patients with respiratory tract infections
    Canduela, Miren J.
    Gallego, Lucia
    Sevillano, Elena
    Valderrey, Cristina
    Calvo, Felicitas
    Perez, Julia
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (06) : 1220 - 1222
  • [8] ACT: the Artemis comparison tool
    Carver, TJ
    Rutherford, KM
    Berriman, M
    Rajandream, MA
    Barrell, BG
    Parkhill, J
    [J]. BIOINFORMATICS, 2005, 21 (16) : 3422 - 3423
  • [9] Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii
    Chen, T.-L.
    Siu, L.-K.
    Wu, R. C.-C.
    Shaio, M.-F.
    Huang, L.-Y.
    Fung, C.-P.
    Lee, C.-M.
    Cho, W.-L.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (08) : 801 - 806
  • [10] Clinical and laboratory Standards Institute, 2007, M100S17 CLSI